Department of Microbiology and Immunology, Canadian Centre for Vaccinology CCfV, Faculty of Medicine, Dalhousie University, Halifax, Canada.
Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
J Infect Dev Ctries. 2022 Jul 28;16(7):1122-1125. doi: 10.3855/jidc.17010.
Mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome continue to threaten the global landscape of the coronavirus disease 2019 (COVID-19) pandemic. The Omicron variant (B.1.1.529) rapidly displaced previous 'variants of concern' (VoC) in 2021 due to its high rate of transmissibility and multitude of mutations. This global influx of infections saturated healthcare systems, overwhelmed testing capacity and case reporting, and increased the COVID-19 death toll. Global health leaders are now being faced with the most transmissible COVID-19 variants yet, the Omicron sublineages BA.4 and BA.5, which contain additional spike protein (S) mutations from previous Omicron and VoC serotypes. With universally observed antibody waning, increasing vaccine-variant mismatch, and resuming international travel, the stage is set for unprecedented levels of breakthrough infections and superspreading events. In this paper, we raise awareness to these novel variants and provide context for the high likelihood of an upcoming wave of infection capable of inflicting significant disease burden on a global scale.
严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)基因组中的突变继续威胁着 2019 年冠状病毒病(COVID-19)大流行的全球格局。由于其高传播率和众多突变,奥密克戎变异株(B.1.1.529)于 2021 年迅速取代了以前的“关注变异株”(VoC)。这种全球感染的涌入使医疗保健系统饱和,检测能力和病例报告不堪重负,并增加了 COVID-19 的死亡人数。全球卫生领导人现在正面临着迄今为止最具传染性的 COVID-19 变异株,即奥密克戎亚谱系 BA.4 和 BA.5,它们包含来自以前的奥密克戎和 VoC 血清型的额外刺突蛋白(S)突变。由于普遍观察到抗体衰减、疫苗变异匹配增加以及恢复国际旅行,突破性感染和超级传播事件将达到前所未有的水平。在本文中,我们提请注意这些新的变异株,并为即将到来的一波感染浪潮提供背景,这一波感染有可能在全球范围内造成严重的疾病负担。